Lv62
3130 积分 2022-04-15 加入
Associations of Coexisting Metabolic Dysfunction‐Associated Steatotic Liver Disease and Sarcopenia‐Related Abnormalities With Adverse Clinical Outcomes Across Obesity States
5天前
已完结
Prediabetes and diabetes as drivers of fibrosis in MASLD: roles of obesity, adipose tissue dysfunction and insulin resistance
9天前
已完结
Global burden of liver disease: 2026 update
10天前
已完结
Weight changes differentially impact MASLD incidence, progression and outcomes based on genetic and metabolic risk profiles
20天前
已完结
EASL-EASD-EASO Guidance for the Use of Resmetirom and Semaglutide as MASH-Targeted Therapy
1个月前
已完结
Histologic Features and Clinical Outcomes of Lean Metabolic Dysfunction-Associated Steatotic Liver Disease
1个月前
已完结
Prevalence of liver fibrosis and steatotic liver disease in community-dwelling adults in China (the CHESS-LiverHealth project): cross-sectional baseline data from a prospective cohort study
1个月前
已完结
Zonated cholesterol sensing by SIRT2 drives MASLD-HCC
1个月前
已完结
Assessing Strategies to Mitigate the Effect of Age When Using FIB-4 Index to Screen for MASLD-Related Liver Fibrosis
1个月前
已关闭
Proteomic insights of peripheral artery disease across the glycemic spectrum: a prospective cohort study
1个月前
已完结
皖公网安备34019202002308
